Northcape Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
2,974
+371
+14% +$127K 0.28% 73
2026
Q1
$916K Sell
2,603
-517
-17% -$184K 0.25% 79
2025
Q4
$1.02M Buy
3,120
+454
+17% +$144K 0.29% 76
2025
Q3
$752K Buy
2,666
+2
+0.1% +$580 0.22% 82
2025
Q2
$744K Buy
2,664
+61
+2% +$17.3K 0.23% 80
2025
Q1
$811K Buy
2,603
+9
+0.3% +$2.66K 0.26% 74
2024
Q4
$676K Sell
2,594
-6,246
-71% -$1.85M 0.22% 82
2024
Q3
$2.85M Buy
8,840
+5,762
+187% +$1.88M 0.93% 38
2024
Q2
$962K Buy
3,078
+1,276
+71% +$375K 0.35% 69
2024
Q1
$512K Sell
1,802
-159
-8% -$46.5K 0.19% 90
2023
Q4
$565K Sell
1,961
-265
-12% -$72.2K 0.2% 87
2023
Q3
$598K Sell
2,226
-185
-8% -$46.2K 0.23% 85
2023
Q2
$535K Sell
2,411
-29
-1% -$6.73K 0.19% 93
2023
Q1
$590K Buy
2,440
+1,492
+157% +$366K 0.21% 87
2022
Q4
$249K Sell
948
-8,735
-90% -$2.34M 0.14% 70
2022
Q3
$2.18M Buy
9,683
+7,991
+472% +$1.94M 0.78% 48
2022
Q2
$412K Sell
1,692
-8,004
-83% -$1.96M 0.16% 85
2022
Q1
$2.35M Buy
9,696
+7,978
+464% +$1.83M 0.68% 48
2021
Q4
$387K Buy
+1,718
New +$363K 0.13% 93

Other funds holding AMGN

Northcape Wealth Management's AMGN Position: Q2 2026 in Review

Northcape Wealth Management increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $127K and bringing the position to 2,974 shares worth $1.08M. The position accounts for 0.28% of the portfolio, ranked #73.

Northcape Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.85M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Northcape Wealth Management held 2,974 shares of Amgen worth $1.08M as of Q2 2026.
  • Northcape Wealth Management bought 371 Amgen shares in Q2 2026, an estimated $127K.
  • Amgen made up 0.28% of Northcape Wealth Management's portfolio in Q2 2026, its #73 holding.
  • Northcape Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Northcape Wealth Management's Amgen position peaked at $2.85M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.